Package 69097-878-02

{"route": ["ORAL"], "spl_id": "a9b85841-5a69-4df1-a22d-3d4cf174e9a6", "openfda": {"upc": ["0369097879037", "0369097878030", "0369097877033"], "unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["9d2c209b-248e-4e26-9cde-fe0abe4428c1"], "manufacturer_name": ["Cipla USA Inc.,"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-02)", "package_ndc": "69097-878-02", "marketing_start_date": "20160725"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-03)", "package_ndc": "69097-878-03", "marketing_start_date": "20160725"}, {"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-07)", "package_ndc": "69097-878-07", "marketing_start_date": "20160725"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-878-12)", "package_ndc": "69097-878-12", "marketing_start_date": "20160725"}], "brand_name": "BUPROPION HYDROCHLORIDE (SR)", "product_id": "69097-878_a9b85841-5a69-4df1-a22d-3d4cf174e9a6", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "69097-878", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Cipla USA Inc.,", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE (SR)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206674", "marketing_category": "ANDA", "marketing_start_date": "20160725", "listing_expiration_date": "20261231"}